Meropenem-induced thrombocytopenia: a paediatric case
Authors:
Open Access
- 3 September 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (9) , e243443
Abstract
Meropenem is a broad-spectrum carbapenem widely used to treat both Gram-positive and negative bacterial infections, including extended-spectrum beta-lactamase-producing microbes. We describe the occurrence of thrombocytopenia and hypersensitivity in a boy receiving intravenous meropenem for intra-abdominal sepsis secondary to perforated appendicitis. The patient developed a pruritic maculopapular rash with occasional petechiae, associated with severe thrombocytopenia, after 7 days of meropenem administration. Investigations for other causes of thrombocytopenia, including possible line sepsis, were unfruitful, and the thrombocytopenia did not resolve until cessation of meropenem. Drug-induced reactions should be considered in children receiving meropenem who present with a rash and thrombocytopenia.Keywords
This publication has 29 references indexed in Scilit:
- A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopeniaJournal of Thrombosis and Haemostasis, 2012
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementJournal of Thrombosis and Haemostasis, 2009
- Drug-induced thrombocytopenia: pathogenesis, evaluation, and managementHematology-American Society Hematology Education Program, 2009
- MeropenemDrugs, 2008
- Drug-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 2007
- Differential diagnosis and management of thrombocytopenia in childhoodPediatric Clinics of North America, 2004
- Bone marrow aplasia and meropenem in a paediatric patientBritish Journal of Haematology, 2000
- Teicoplanin-Induced ThrombocytopeniaNephron, 1996
- Thrombocytopenia Due to Use of TeicoplaninClinical Infectious Diseases, 1993
- Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulationAntimicrobial Agents and Chemotherapy, 1987